查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589598

藥物輸送市場：口服藥物輸送，按設備類型、分銷管道、應用分類 - 2025-2030 年全球預測

Drug Delivery Market by Oral Drug Delivery (Injectable Drug Delivery, Nasal Drug Delivery, Ocular Drug Delivery), Device Type (Advanced, Conventional), Distribution Channels, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年給藥市值為17.2億美元，預計到2024年將達到18.2億美元，複合年成長率為6.41%，預計到2030年將達到26.5億美元。

藥物輸送市場包括各種旨在以受控方式施用治療物質以實現特定結果的技術。這對於提高藥物療效、患者依從性和安全性至關重要。藥物傳遞系統包括錠劑和注射等傳統載體，以及奈米粒子、脂質體和水凝膠等先進技術。藥物（包括生技藥品和個人化醫療）日益複雜，需要精確靶向和控制釋放，這推動了對創新藥物輸送系統的需求。應用範圍涵蓋製藥、生物技術、醫院和診所，最終使用場景專注於慢性病管理、癌症治療、疫苗傳輸和診斷。

主要市場統計
基準年[2023] 17.2億美元
預測年份 [2024] 18.2億美元
預測年份 [2030] 26.5億美元
複合年成長率（%） 6.41%

市場受到慢性病盛行率上升、技術進步和研發投資增加等因素的顯著影響。物聯網和人工智慧等智慧技術的集合成為建構智慧交付系統創造了機會，進一步提高準確性和監控能力。生物感測器和生物有效性增強劑代表了一條有前途的發展途徑。為了利用這些機會，企業應專注於與高科技公司和研究機構的夥伴關係關係，以創新下一代交付平台。

然而，市場面臨嚴格的法律規範和開發先進交付系統的高成本的限制，這阻礙了中小企業的發展。此外，諸如需要專業知識以及將新興技術整合到現有框架中的複雜性等挑戰構成了重大障礙。儘管如此，創新的時機已經成熟，包括開發針對個別患者情況的非侵入性給藥方法和個人化給藥系統，這將顯著提高採用率。了解市場動態和消費者需求對於企業成功駕馭不斷變化的環境至關重要。藥物輸送市場的特點是技術創新速度快、投資潛力大，企業準備克服監管和技術挑戰，滿足對高效和有效的治療解決方案不斷成長的需求，提供了廣泛的商機。

市場動態：揭示快速發展的藥物傳輸市場的關鍵市場洞察

供需的動態交互作用正在改變藥物輸送市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球生技藥品的使用增加
    • 對有效藥物輸送機制的需求不斷成長
    • 慢性病顯著增加
  • 市場限制因素
    • 藥品召回和失敗的增加
    • 與藥物相關的副作用和風險
  • 市場機會
    • 對具有成本效益的醫療的需求不斷成長
    • 對居家照護和自我管理的興趣日益濃厚
  • 市場問題
    • 價格壓力與專利到期問題

波特五力：駕馭給藥市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解藥物輸送市場的外部影響

外部宏觀環境因素在塑造給藥市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解給藥市場的競爭格局

對藥物輸送市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣：藥物傳輸市場供應商的績效評估

FPNV定位矩陣是評估藥物傳輸市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製藥物輸送市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，藥物輸送市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地生物藥物的使用增加
      • 對有效藥物輸送機制的需求不斷成長
      • 慢性病顯著增加
    • 抑制因素
      • 藥品召回和缺陷增加
      • 與藥物相關的副作用和風險
    • 機會
      • 對具有成本效益的醫療的需求不斷成長
      • 越來越注重居家照護和自我管理
    • 任務
      • 價格壓力與專利到期問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章 給藥市場：口服給藥

  • 介紹
  • 注射給藥
  • 鼻腔給藥
  • 眼部藥物輸送
  • 肺部藥物輸送
  • 局部給藥

第7章藥物輸送市場：依設備類型

  • 介紹
  • 高級型
  • 傳統的

第8章 藥物傳輸市場：依通路分類

  • 介紹
  • 醫院藥房
  • 零售藥房

第9章 藥物傳輸市場：依應用分類

  • 介紹
  • 癌症
  • 心血管疾病
  • 糖尿病
  • 呼吸系統疾病

第10章美洲給藥市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太藥物傳輸市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的給藥市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Antares Pharma, Inc. by Halozyme Therapeutics, Inc.
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Enable Injections, Inc.
  • Gerresheimer AG
  • Johnson & Johnson Services Inc.
  • Kindeva Drug Delivery
  • Koninklijke Philips NV
  • Merck KGaA
  • Novartis AG
  • nsulet Corporation
  • OraSure Technologies, Inc.
  • Oxford BioMedica PLC
  • Sanofi SA
Product Code: MRR-434CCDA05153

The Drug Delivery Market was valued at USD 1.72 billion in 2023, expected to reach USD 1.82 billion in 2024, and is projected to grow at a CAGR of 6.41%, to USD 2.65 billion by 2030.

The drug delivery market encompasses a range of technologies aimed at administering therapeutic substances in a controlled manner to achieve specific outcomes. This is crucial for improving drug efficacy, patient compliance, and safety. Drug delivery systems can include advanced methodologies like nanoparticles, liposomes, and hydrogels, alongside traditional mediums such as tablets and injections. The necessity of innovative drug delivery systems stems from the increasing complexity of pharmaceuticals, including biologics and personalized medicine, which require precise targeting and controlled release. Applications span across pharmaceuticals, biotechnology, hospitals, and clinics, with end-use scenarios focusing on chronic disease management, cancer therapy, vaccine delivery, and diagnostics.

KEY MARKET STATISTICS
Base Year [2023] USD 1.72 billion
Estimated Year [2024] USD 1.82 billion
Forecast Year [2030] USD 2.65 billion
CAGR (%) 6.41%

The market is significantly influenced by factors such as the rising prevalence of chronic diseases, technological advancements, and increased investment in R&D. Opportunities are emerging through the integration of smart technologies like IoT and AI to create intelligent delivery systems that further enhance precision and monitoring capabilities. Biosensors and bioavailability boosters present promising avenues for development. To capitalize on these opportunities, companies should focus on collaborative partnerships with tech firms and research institutions to innovate next-generation delivery platforms.

However, the market faces limitations from stringent regulatory frameworks and the high cost of developing advanced delivery systems, which can impede smaller companies. Moreover, challenges such as the need for specialized knowledge and the complexity of integrating emerging technologies into existing frameworks also pose significant hurdles. Despite these, areas ripe for innovation include the development of non-invasive delivery methods and personalized drug delivery systems tailored to individual patient profiles, which can significantly enhance adoption rates. Understanding market dynamics and consumer needs will be critical for companies to navigate the shifting landscape successfully. The drug delivery market, characterized by its rapid innovation pace and high investment potential, offers broad opportunities for companies that can overcome regulatory and technological challenges to meet growing demand for efficient and effective treatment solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Delivery Market

The Drug Delivery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing use of biological drugs worldwide
    • Swelling demand for effective drug delivery mechanisms
    • Significant increase in chronic diseases
  • Market Restraints
    • Increasing drug recalls and drug failures
    • Side effects and risk associated with the drugs
  • Market Opportunities
    • Rising demand for cost-effective healthcare treatment
    • Growing focus towards home care and self-administration
  • Market Challenges
    • Pricing pressure and issues with patents expiry

Porter's Five Forces: A Strategic Tool for Navigating the Drug Delivery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Delivery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Delivery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Delivery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Delivery Market

A detailed market share analysis in the Drug Delivery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Delivery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Delivery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Delivery Market

A strategic analysis of the Drug Delivery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Delivery Market, highlighting leading vendors and their innovative profiles. These include Antares Pharma, Inc. by Halozyme Therapeutics, Inc., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Enable Injections, Inc., Gerresheimer AG, Johnson & Johnson Services Inc., Kindeva Drug Delivery, Koninklijke Philips N.V., Merck KGaA, Novartis AG, nsulet Corporation, OraSure Technologies, Inc., Oxford BioMedica PLC, and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Oral Drug Delivery, market is studied across Injectable Drug Delivery, Nasal Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, and Topical Drug Delivery.
  • Based on Device Type, market is studied across Advanced and Conventional.
  • Based on Distribution Channels, market is studied across Hospital Pharmacies and Retail Pharmacies.
  • Based on Application, market is studied across Cancer, Cardiovascular Diseases, Diabetes, and Respiratory Diseases.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use of biological drugs worldwide
      • 5.1.1.2. Swelling demand for effective drug delivery mechanisms
      • 5.1.1.3. Significant increase in chronic diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Increasing drug recalls and drug failures
      • 5.1.2.2. Side effects and risk associated with the drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising demand for cost-effective healthcare treatment
      • 5.1.3.2. Growing focus towards home care and self-administration
    • 5.1.4. Challenges
      • 5.1.4.1. Pricing pressure and issues with patents expiry
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Drug Delivery Market, by Oral Drug Delivery

  • 6.1. Introduction
  • 6.2. Injectable Drug Delivery
  • 6.3. Nasal Drug Delivery
  • 6.4. Ocular Drug Delivery
  • 6.5. Pulmonary Drug Delivery
  • 6.6. Topical Drug Delivery

7. Drug Delivery Market, by Device Type

  • 7.1. Introduction
  • 7.2. Advanced
  • 7.3. Conventional

8. Drug Delivery Market, by Distribution Channels

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Retail Pharmacies

9. Drug Delivery Market, by Application

  • 9.1. Introduction
  • 9.2. Cancer
  • 9.3. Cardiovascular Diseases
  • 9.4. Diabetes
  • 9.5. Respiratory Diseases

10. Americas Drug Delivery Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Drug Delivery Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Drug Delivery Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Antares Pharma, Inc. by Halozyme Therapeutics, Inc.
  • 2. B. Braun SE
  • 3. Baxter International Inc.
  • 4. Becton, Dickinson and Company
  • 5. Enable Injections, Inc.
  • 6. Gerresheimer AG
  • 7. Johnson & Johnson Services Inc.
  • 8. Kindeva Drug Delivery
  • 9. Koninklijke Philips N.V.
  • 10. Merck KGaA
  • 11. Novartis AG
  • 12. nsulet Corporation
  • 13. OraSure Technologies, Inc.
  • 14. Oxford BioMedica PLC
  • 15. Sanofi S.A.

LIST OF FIGURES

  • FIGURE 1. DRUG DELIVERY MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG DELIVERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG DELIVERY MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG DELIVERY MARKET SIZE, BY INJECTABLE DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG DELIVERY MARKET SIZE, BY NASAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG DELIVERY MARKET SIZE, BY OCULAR DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG DELIVERY MARKET SIZE, BY PULMONARY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG DELIVERY MARKET SIZE, BY TOPICAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG DELIVERY MARKET SIZE, BY ADVANCED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG DELIVERY MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG DELIVERY MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG DELIVERY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DRUG DELIVERY MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG DELIVERY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DRUG DELIVERY MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG DELIVERY MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023